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beams were acceptable within the clinical tolerances of this 
institution: ≥95% of points passed a gamma analysis of 3%/3mm and 
PTV point dose within 2% of calculations. The treatment delivery 
times for the 6XFFF plans were approximately 1min faster than the 6X 
treatments. 
 
Parameter Units Average Values 
  6X 6XFFF 
PTV Volume CC (14.65 - 40.50) 
Dose to 95% of PTV Gy 55.1 55.1 
Dose to 99% of PTV Gy 53.4 53.2 
R100  1.13 1.12 
R50  5.18 5.01 
Dose@2cm Gy 31.6 31.4 
Mean lung Dose Gy 3.1 3.1 
V 20 Lung % 3.6 3.4 
Max. PTV Dose Gy 70.0 69.5 
Total MU  1657 2071 
Beams / segments  50 52 
Delivery time sec 175 108 
Table 1: Comparison of 6X and 6XFFF plans produced on Monaco. 
 
Conclusions: The use of FFF beams for lung VMAT SABR produces 
plans of comparable quality to those produced by flattened beams and 
have the advantage of decreased delivery times, even with a mid-line 
isocentre technique. The VMAT optimisation parameters did not alter 
significantly from those used for flattened beams and therefore 
implementation of FFF beams requires minimal changes to the 
established planning process. 
*1: Elekta AB, Sweden. 
*2: ScandiDos AB, Sweden. 
*3: ComputerizedImaging Reference Systems Inc, USA. 
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Purpose/Objective: To compare the planning target volume (PTV) 
coverage and the dose distribution to normal tissues in mediastinal 
Hodgkin’s disease (HD) patients, treated with 30Gy, using four 
different techniques: Three Dimensional Conformal RadiationTherapy 
(3D-CRT), Intensity Modulated Radiation Therapy (IMRT), Volumetric 
Modulated Arc Therapy (VMAT) and Helical Tomotherapy (HT). 
Materials and Methods: 10 patients with Stage II A-B HD were 
historically treated with involved-field 3D-CRT. Two experimental 
plans were calculated for each technique for each single patient: the 
first optimized for PTV coverage, the second for reduction of lung 
doses. IMRT static fields plans were evaluated both with a 5 and an 8 
field combination. Therefore 9 plans were calculated for each 
patient. The optimal PTV coverage was considered D95 and D98 > 95% 
of dose prescription; the optimal dose constraints for the lungs were 
considered V20 <20% and V5<50%. The doses to PTV and to organs at 
risk (lungs, heart, spinal cord and esophagus) were compared. A direct 
comparison of the different plans was performed. The best of the 
experimental plans was then compared with the plan used to treat the 
patient. Differences were considered statistically significant if p<0.01 
(T-student test for paired data). 
Results: 8 fields IMRT, compared to 5 fields one, allows similar target 
coverage and significant dose reduction to the lungs(p<0,005). VMAT 
plans, as 8 fields-IMRT, guarantees PTV coverage when the goal is the 
lung doses reduction, but with more dose conformation to target. 
Lung and esophagus doses with HT are lower than with VMAT 
(p<0,005). Compared with 3D-CRT, HT provides a better PTV coverage 
(p<0.005) and a lower dose to the spinal cord (p<0.005). About the 
lungs, only 3D-CRT allows to respect the constraints for low doses (V5 
<50%) (p <0.005) but with the inconvenient of an increase in high 
doses regions (V20 and V30); HT shows instead a significant advantage 
in V20 and V30 values but with significant worse V5 (p<0,005). The 
statistical differences in OAR dose distribution and PTV coverage of 
3DCRT versus HT (PTV coverage and lung optimization) are shown in 
Tab1. 
 
Tab 1 (better values in bold) 
  3DCRT HT PTV 
coverage 
p HT lung 
optimization  
p 
PTV Dmax 32.2 
Gy 
31Gy <0.005 31.1 Gy <0.005
D95 28 Gy 29.4 Gy <0.005 29.1 Gy <0.001
D98 27 Gy 29 Gy <0.005 28.5 Gy n.s. 
spinal 
cord 
Dmax 30.1 
Gy 
22.2 Gy <0.005 22.4 Gy <0.005
Lung V5 37.6% 52.2% <0.005 47.9% <0.01 
V20 18.1% 11.6% <0.005 11.3% <0.005
V30 1.5% 0.1% <0.005 0.1% <0.005
Heart Dmax 30.5 
Gy 
30.4 Gy n.s. 30.5 Gy n.s. 
Davg 10.5 
Gy 
9.4 Gy n.s.  9.4 Gy n.s.  
Esophagus Dmax 29.7 
Gy 
30.4 Gy n.s. 30.4 Gy n.s. 
Davg 19.5 
Gy 
15.6 Gy n.s.  15.8 Gy n.s. 
CI D95 3.3 1.5  <0.005 1.5  <0.005
 
Conclusions: The dose distributions obtained with HT seem to be 
better than with the other techniques, allowing a high target coverage 
and a reduction of high doses to lungs and spinal cord. However it is 
necessary to evaluate the late effects of larger volumes exposed to 
low doses, in long-term survivors. 
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Purpose/Objective: To compare the planning target volume (PTV) 
coverage and the dose distribution to normal tissues in patients with 
lung cancer, treated, after surgery, on mediastinal lymph nodes, using 
four different techniques: Three Dimensional Conformal Radiation 
Therapy(3D-CRT), Intensity Modulated Radiation Therapy (IMRT), 
Volumetric ModulatedArc Therapy (VMAT) and Helical Tomotherapy 
(HT). 
Materials and Methods: 9 patients with lung cancer treated after 
surgery on mediastinal lymph-nodes were selected, 5 with a dose 
prescription of 50.4 Gy (1.8 Gy/fraction) and 4 with a dose 
prescription of 50 Gy (2 Gy/fraction). For each technique we 
calculated two plans: the first optimized for PTV coverage and the 
second for lung doses reduction. The optimal PTV coverage was 
considered D95and D98 > 95% of dose prescription; the optimal dose 
constrains for the lungs were considered V20 <20% and V5<50% . IMRT 
static fields plans were evaluated both with a 5 and an 8 field 
combination. For tomotherapy plans optimized for the reduction of 
lung doses, one plan was calculated with a collimation width of 1 cm 
(the other ones have a collimation width of 2.5 cm).Therefore 10 
plans were calculated for each patient. The doses to PTV andorgans at 
risk were compared. The best of the experimental plan was then 
compared with the plan used to treat the patient. Differences were 
considered statistically significant if p<0.01 (T-student test for paired 
data). 
Results: IMRT with 8 fields, compared to IMRT with 5 fields, allows to 
get better PTV coverage and to reduce lung doses (p<0.05). With 
VMAT the lung V20 and V30 are smaller than those obtained with 
IMRT(p<0.05), but VMAT does not allow to maintain PTV coverage. 
Tomotherapy allows to reduce high doses to the organs at risk, but at 
the expense of larger lung V5. With 3D-CRT lung doses respect the 
limits imposed, but PTV coverage is worse than that obtained with 
IMRT. A statistical correlation demonstrated that there is a direct 
correlation between 'PTV length/lung length' ratio and lungs V5 for 
3D-CRT, IMRT with 8 fields and VMAT plans and there is an inverse 
correlation between 'PTV length-lung length' ratio and PTV D95 
forTomotherapy plans. (Tab 1) 
